20 PCH

20 PCH

Piroxicam 10 PCH

Piroxicam 10 PCH

Lansoprazol 30 mg PCH, 30 mg maagsapresistente capsule
http://www.emea.europa.eu/

Lansoprazol TEVA 15 mg enterokapseler, harde
http://www.emea.europa.eu/

Pharmachemie B. V (PCH) Swensweg 5 Haarlem The Netherlands

Pharmachemie B. V (PCH) Swensweg 5 Haarlem Pays-Bas

Swensweg 5, Postbus 552, 2003 RN Haarlem The Netherlands Pharmachemie B. V.Swensweg 5, Postbus 552, 2003 RN Haarlem The Netherlands4maagsapresistente capsuleLansoprazol 30 mg PCH, 30 mg maagsapresistente capsule

30 mg15 mg30 mgGélule gastro-résistante Gélule gastro-résistante Gélule gastro-résistante

Lansoprazol15 mg PCH, 15 mgGastro-resistantOral useThe NetherlandsUnited KingdomUnited KingdomTEVA UK Limited Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG United Kingdom TEVA UK Limited Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG United Kingdom

Swensweg 5, Postbus 552, 2003 RN Haarlem The NetherlandsTeva Pharma B. V., Industrieweg 23, P. O.Box 217, 3640 AE Mijdrecht, The Netherlands,Teva Pharmaceuticals Polska Sp. z o. o.E.Plater 53, 00-113 Warsaw PolandLansoprazole TEVA 15 mg Gastro-resistant Capsules Lansoprazole TEVA 30 mg Gastro-resistant Capsules Lansoprazol 15 mg PCH, maagsapresistente capsule Lansoprazol 30 mg PCH, maagsapresistente capsule Lansoprazol TEVA 15 mg enterokapseler, harde Lansoprazol TEVA 30 mg enterokapseler, harde LansoTEVA 15 mg kapsulka dojelitowa twarda LansoTEVA 30 mg kapsulka dojelitowa twarda 315 mg30 mg15 mg30 mg15 mg

Jeneweinova 51a, 617 00 Brno, Czech RepublicPharmachemie B. V.Swensweg 5, Postbus 552, 2003 RN Haarlem The Netherlands TEVA Sweden AB PO Box 1070, SE -25110 Helsingborg SwedenTEVA Pharma -Produtos Farmacêuticos Lda Lagoas Park, Edifício 1, Piso 3, 2740-264 Porto Salvo, Portugal Ingers Industrial Solutions s. r. o.Jeneweinova 51a, 617 00 Brno, Czech RepublicBicalutamide 150 PCH, filmomhulde tabletten 150 mg Bicalutamid TEVA 150 mg tabletter, filmdrasjerteBicalutamide Ingers 150 mg tabletki powlekaneBicalutamida Teva

Teva Pharma B. V.Industrieweg 23, P. O.Box 217 3640 AE Mijdrecht Pays Bas Ingers Industrial Solutions s. r. o.Bikalutamid TEVA 150 mg filmsko oblozene tablete Bicalutamide Teva

1. On 19 October 2006, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [1] by which the undertaking Johnson%amp% Johnson ("J%amp%J", USA), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of part of the undertaking Pfizer Inc. ("Pfizer", USA), namely Pfizer's entire consumer healthcare division, Pfizer Consumer Health Care ("PCH", USA), by way of purchase of shares and assets.

1. Le 19 octobre 2006 la Commission a reçu notification, conformément à l'article 4 du règlement (CE) no 139/2004 du Conseil [1], d'un projet de concentration par lequel l'entreprise Johnson%amp% Johnson ("J%amp% J", États-Unis) acquiert, au sens de l'article 3, paragraphe 1, point b), du règlement du Conseil, le contrôle d'une partie de l'entreprise Pfizer Inc. ("Pfizer", États-Unis), à savoir sa division Pfizer Consumer Healthcare ("PCH"), par achat d'actions et d'actifs.